Skip to content

The effect of taking the extract of six plants in improving the symptoms of prostate enlargement.

Investigating the effect of the extract of six plants in improving the symptoms of prostate enlargement in patients with benign prostate enlargement with mild to moderate symptoms: a double-blind clinical trial study.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241219064101N1
Enrollment
62
Registered
2025-03-10
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with benign prostate enlargement with mild to moderate lower urinary symptoms. Enlarged prostate with lower urinary tract symptoms

Interventions

Intervention 1: Intervention group: included 31 patients who, after filling out the international prostate symptom questionnaire, were in the mild to moderate symptom category and met other inclusion

Sponsors

Nooshin Shahd Urmia Company
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 50 years old Mild to moderate lower urinary tract symptoms Not receiving drug treatment before entering the study

Exclusion criteria

Exclusion criteria: History of prostate surgery Disagreement to participate in the study. History of urethral stricture. Active urinary infection. Bladder stones. Kidney failure. Ecurrent urinary infection. History of allergy to six herbal medicinal compounds. Known case Prostate cancer. People with diabetes and previous problems and a history of chemotherapy.

Design outcomes

Primary

MeasureTime frame
Score of International Prostate Symptoms (IPSS) questionnaire. Timepoint: Before starting the intervention and after 40 days. Method of measurement: A total of 62 patients with data such as age, prostate volume, residual urine, and bladder wall thickness before and after treatment are collected in the form of the IPSS questionnaire. Any complications during treatment, including urinary tract infection and urinary retention, etc., are also recorded. The IIEF5 questionnaire is also completed for all men before and after the study. In addition, the subjects are asked about any side effects of the drug, both sexual (erectile dysfunction, premature ejaculation, retrograde ejaculation) and non-sexual. They are entered into the study and randomly divided into two groups using a number table. Both groups are given the necessary nutritional recommendations. Then, one group is given the extract of six fern plants and the other group is given the drug. It is recommended that they take the prescribed drugs according to the instructions of the drug manufacturer for 40 days. (Take 10 cc of the herbal extract three times a day and each time, and take one specific alpha-blocker drug every night.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirhossein Rahavian

Yazd Shahid Sadoughi University of Medical Sciences Campus

amirrahavian@yahoo.com+98 35 3525 0480

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026